Full-Time

Head of Marketing

Posted on 8/21/2026

Inato

Inato

51-200 employees

Marketplace connecting doctors to clinical trials

Compensation Overview

$230k - $250k/yr

Remote in USA

Remote

Must work in the Eastern Time Zone.

Category
Growth & Marketing (2)
,
Required Skills
Communications
Marketing

Get referred to Inato

See people who can refer or advise you

Requirements
  • Experience leading B2B SaaS marketing at a high-growth company selling complex enterprise solutions.
  • Proven success building and scaling account-based marketing programs for large strategic accounts.
  • Deep product marketing expertise, including establishing positioning, messaging, and go-to-market strategy while coaching and developing product marketing talent.
  • Knowledge of the communications function and experience collaborating with communications teams to create consistent, effective messaging and positioning.
  • Demonstrated ability to partner closely with enterprise sales organizations on long sales cycles and complex buying committees.
  • Experience leading and developing high-performing marketing teams.
  • Ability to use analytical and data-driven approaches focused on business outcomes over traditional marketing activity metrics.
  • Ability to operate in a fast-moving environment where strategy and execution go hand in hand.
Responsibilities
  • Lead and develop the marketing organization by providing strategic direction, prioritization, coaching, and career development for the existing team.
  • Build and scale an account-based marketing strategy focused on enterprise sponsors and strategic partnerships.
  • Partner closely with Sales to develop integrated campaigns that accelerate pipeline creation, deal progression, and customer expansion.
  • Shape Inato's product marketing strategy and develop internal product marketing expertise across the team, ensuring clear positioning, differentiated messaging, and effective go-to-market execution.
  • Develop customer marketing programs that increase adoption, strengthen executive relationships, and create customer advocacy.
  • Establish marketing goals, metrics, and operating rhythms that connect marketing investments to business outcomes.
  • Work cross-functionally with Product, Customer Success, Strategy, and Executive Leadership to ensure consistent go-to-market execution.

Inato operates a marketplace that connects doctors with suitable clinical trials, making trials easier to access for physicians. Doctors can browse and filter trials by specialty, location, and eligibility, while sponsors post studies and reach a larger pool of eligible physicians; the platform streamlines communication and referrals to speed up the research workflow. Unlike traditional site-by-site recruitment, Inato focuses on direct doctor-to-study matching to improve efficiency. Its goal is to increase physician participation and patient access to trials, improving outcomes for both clinicians and sponsors.

Company Size

51-200

Company Stage

Series A

Total Funding

$49.2M

Headquarters

Paris, France

Founded

2016

Get referred to Inato

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • February 2026 SCOPE Orlando showed Inato pushing data-driven site selection and enrollment wins.
  • RealTime partnership adds 50 networks and 2,000 sites, expanding qualified site supply in 2025.
  • July 2026 materials claim up to 90% faster chart review, driving site adoption and sponsor pull.

What critics are saying

  • Free pre-screening on marketplace.inato.com commoditizes the product and weakens pricing power in 2026.
  • RealTime-Devana, CRIO, and eClinPro can disintermediate Inato by owning site workflow data.
  • If sponsors buy AI screening directly from CTMS vendors, Inato becomes an exchange layer only.

What makes Inato unique

  • Inato connects sponsors and community sites, with 6,000+ sites and 25+ sponsors by 2025.
  • January 2026 CRIO and April 2026 eClinPro integrations embed screening into site workflows.
  • Its AI pre-screening de-identifies records and scores eligibility without EMR or CTMS integration.

Help us improve and share your feedback! Did you find this helpful?

Benefits

6 weeks vacation

9 holidays + 4 floating holidays

16 weeks of paid maternity leave

Comprehensive health insurance

Competitive salary & equity

Growth & Insights and Company News

Headcount

6 month growth

1%

1 year growth

2%

2 year growth

2%
Clinical Trials Arena
Sep 24th, 2025
Inato partners with RealTime for clinical trial enrolment

Inato partners with RealTime for clinical trial enrolment.

HIT Consultant
Jan 28th, 2025
Inato Launches Ai-Powered Patient Pre-Screening To Reduce Site Burden And Accelerate Enrollment

What You Should Know:–       Inato, the leading platform for clinical trial access and inclusivity, today unveiled new capabilities to help research sites efficiently pre-screen patients for trial opportunities.–       The company’s latest advancement integrates a series of artificial intelligence (AI) models into a unified agent that quickly and securely reviews patient records and assesses eligibility, transforming a historically time-consuming and cumbersome process for sites. Inato: Revolutionizing Clinical Trial Access with AI-Driven SolutionsInato is on a mission to democratize clinical research, ensuring every patient has access to trials regardless of location. By integrating trial planning, site selection, and patient pre-screening into a single AI-powered platform, Inato enhances collaboration among research sites, sponsors, and Contract Research Organizations (CROs). Trusted by leading pharmaceutical companies and utilized by thousands of research sites, Inato streamlines trial operations and improves trial accessibility and representation.Tackling the Patient Enrollment ChallengePatient enrollment remains a significant bottleneck in clinical trials, now taking 25% longer than it did five years ago. Factors such as growing trial complexity, increasing trial sizes, and heightened competition for participants threaten to exacerbate this issue. Leveraging advancements in generative AI, Inato addresses these challenges by:Streamlining patient identification and eligibility reviews.Reducing site burden through efficient AI-driven processes.Accelerating trial timelines while maintaining accuracy and compliance.Transformative AI-Powered Pre-ScreeningInato’s AI-enabled patient pre-screening feature, now available across the United States, significantly optimizes the patient evaluation process without requiring EMR or CTMS integration. Key capabilities include:Assessing patient records against inclusion and exclusion criteria in minutes, with 95% accuracy.Reducing pre-screening times by more than 50%, and up to 90% for early adopters.Empowering site staff to make informed, rapid decisions about patient eligibility.The platform employs an AI agent to de-identify patient records, identify relevant trials, and evaluate eligibility based on complex criteria

Frontlines
Nov 2nd, 2023
Kourosh Davarpanah, Co-Founder and CEO of Inato: Over $35 Million Raised to Build the Future of Clinical Trials

In today's episode of Category Visionaries, Frontlines speak with Kourosh Davarpanah, Co-Founder and CEO of Inato, a global clinical trial platform that's raised over $35 Million in funding.

Health Transformer
Apr 4th, 2023
StartUp Health Insights: This Week’s Trends in Global Health Tech Funding | Week of Apr 4, 2023 | by StartUp Health | Apr, 2023 | StartUp Health

Eli Health, a Montréal, Quebec-based healthtech company working on a saliva-based hormone testing solution, raised C$5M ($3.7M) led by Muse Capital, with participation from RH Capital, Cake Ventures, TELUS Pollinator Fund For Good, Garage Capital, Leva Capital, Real Ventures, Panache, Vectr, and MEDTEQ+.

PR Newswire
Mar 23rd, 2022
Inato hired Liz Beatty as Board of Directors on Mar 23rd 22'.

Inato, the leading clinical trial platform for community sites, today announced the appointment of Liz Beatty to its Board of Directors.